ChoA Pharmaceutical Co., LTD. Logo

ChoA Pharmaceutical Co., LTD.

Develops, manufactures, and sells pharmaceutical products and health supplements.

034940 | KO

Overview

Corporate Details

ISIN(s):
KR7034940007
LEI:
Country:
South Korea
Address:
서울특별시 영등포구 당산로2길 12 에이스테크노타워 101호(문래동3가, 에이스테크노타워1층), 서울특별시

Description

ChoA Pharmaceutical Co., LTD., established in 1988, is a company engaged in the development, manufacturing, and sale of pharmaceutical products and health supplements. The company's portfolio comprises approximately 200 products, including over-the-counter (OTC) drugs, generic medications, and functional health foods. It offers a diverse range of formulations such as tablets, capsules, granules, ampoules, and a notable selection of liquid and drinkable products. ChoA Pharmaceutical primarily supplies pharmacies and maintains a global business presence, exporting its products to more than 20 countries. The company focuses on developing high-quality medicines and health-related products to contribute to public well-being.

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Bulk Actions:
Date Filing Language Size Actions
2025-08-14 00:00
반기보고서 (2025.06)
Korean 1.2 MB
2025-05-15 00:00
분기보고서 (2025.03)
Korean 1.0 MB
2025-03-24 00:00
정기주주총회결과
Korean 22.3 KB
2025-03-14 00:00
감사보고서제출
Korean 25.8 KB
2025-03-14 00:00
사업보고서 (2024.12)
Korean 586.6 KB
2025-02-28 00:00
주주총회소집공고
Korean 137.2 KB
2025-02-28 00:00
의결권대리행사권유참고서류
Korean 139.1 KB
2025-02-21 00:00
주주총회소집결의
Korean 11.1 KB
2025-02-21 00:00
매출액또는손익구조30%(대규모법인은15%)이상변동
Korean 11.3 KB
2025-02-03 00:00
생산재개(자율공시)
Korean 7.8 KB
2024-12-12 00:00
주주명부폐쇄기간또는기준일설정
Korean 4.1 KB
2024-12-10 00:00
생산중단
Korean 8.9 KB
2024-11-14 00:00
분기보고서 (2024.09)
Korean 934.8 KB
2024-08-14 00:00
반기보고서 (2024.06)
Korean 1.0 MB
2024-05-17 00:00
계열회사변경(자율공시)
Korean 6.7 KB

Automate Your Workflow. Get a real-time feed of all ChoA Pharmaceutical Co., LTD. filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

Unlock Full Financials for ChoA Pharmaceutical Co., LTD.

This data is available as part of our premium data solutions. Contact our team for access.

Need More History? Access decades of standardized financials for ChoA Pharmaceutical Co., LTD. via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

4BASEBIO PLC Logo
Manufactures GMP-grade synthetic DNA for next-generation therapeutics and vaccines.
United Kingdom
4BB
4D Molecular Therapeutics, Inc. Logo
Develops genetic medicines using AAV vectors for ophthalmology and pulmonology diseases.
United States of America
FDMT
4SC AG Logo
Biopharmaceutical company with no products under development or operational business.
Germany
VSC
60 DEGREES PHARMACEUTICALS, INC. Logo
Develops and commercializes medicines for infectious diseases, focusing on tropical illnesses.
United States of America
SXTP
89bio, Inc. Logo
Clinical-stage biopharma developing therapies for liver and cardiometabolic diseases.
United States of America
ETNB
Aardvark Therapeutics, Inc. Logo
Clinical-stage biopharma developing therapeutics for hunger and metabolic diseases.
United States of America
AARD
ABBOTT LABORATORIES Logo
Global healthcare company in medical devices, diagnostics, nutrition & pharmaceuticals.
United States of America
ABT
AbbVie Inc. Logo
A research-based biopharmaceutical company developing and manufacturing medicines.
United States of America
ABBV
AbCellera Biologics Inc. Logo
Discovers and develops antibody-based therapeutics using a proprietary platform.
United States of America
ABCL
Develops antibody-based therapeutics using CAR-T, NEST, and AffiMab platforms.
South Korea
174900

Report Sent!

Thank you. We will check the data and update it shortly.

Talk to a Data Expert

Have a question? We'll get back to you promptly.